Results 21 to 30 of about 34,514 (296)

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundInadvertent damage to leads for transvenous pacemakers, implantable cardioverter‐defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator‐replacement procedures.
Christine I. Nichols, Joshua G. Vose, Suneet Mittal   +2 more
doaj   +1 more source

The death of cost-minimization analysis? [PDF]

, 2001
Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by
Bernie J. O'Brien, Andrew H. Briggs, O'Brien, B.J., Briggs, A.H.   +3 more
core   +1 more source

New horizon for infection prevention technology and implantable device

Journal of Arrhythmia, 2016
There has been a significant increase in the number of patients receiving cardiovascular implantable electronic devices (CIED) over the last two decades.
Yusuke Kondo, MD, PhD, Marehiko Ueda, MD, PhD, Yoshio Kobayashi, MD, PhD, Joerg O. Schwab, MD, PhD   +3 more
doaj   +1 more source

Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Patients with Brugada syndrome (BrS) are recommended to avoid drugs that may increase their risk of arrhythmic events. We examined treatment with such drugs in patients with BrS after their diagnosis.
Camilla H. B. Jespersen, Johanna Krøll, Priya Bhardwaj, Carl Johann Hansen, Jesper Svane, Bo G. Winkel, Christian Jøns, Peter Karl Jacobsen, Jens Haarbo, Jens Cosedis Nielsen, Jens Brock Johansen, Berit T. Philbert, Sam Riahi, Christian Torp‐Pedersen, Lars Køber, Jacob Tfelt‐Hansen, Peter E. Weeke   +16 more
doaj   +1 more source

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Cardiac sympathetic denervation (CSD) has been used as a bailout strategy for refractory ventricular tachycardia (VT). Risk of VT recurrence in patients with scar‐related monomorphic VT referred for CSD and the extent to which CSD can modify ...
Veronica Dusi, Jeffrey Gornbein, Duc H. Do, Julie M. Sorg, Houman Khakpour, Yuliya Krokhaleva, Olujimi A. Ajijola, Carlos Macias, Jason S. Bradfield, Eric Buch, Osamu A. Fujimura, Noel G. Boyle, Jane Yanagawa, Jay M. Lee, Kalyanam Shivkumar, Marmar Vaseghi   +15 more
doaj   +1 more source

The implantable cardioverter‐defibrillator [PDF]

Clinical Cardiology, 2000
AbstractVentricular arrhythmias remain a major cause of cardiovascular mortality. Therapy for serious ventricular arrhythmias has evolved over the past decade, from treatment primarily with antiarrhythmic drugs to implanted devices. The implantable cardioverter‐defibrillator (ICD) is the best therapy for patients who have experienced an episode of ...
openaire   +2 more sources

Subcutaneous Implantable Cardioverter Defibrillator [PDF]

Circulation: Arrhythmia and Electrophysiology, 2012
Implantable cardioverter-defibrillators (ICDs) represent a very effective therapy for primary and secondary prevention of sudden cardiac death (SCD). However, implantation of endocardial leads using a transvenous approach is associated with significant procedural and long term complications.
Christopher P, Rowley, Michael R, Gold
openaire   +2 more sources

Effectiveness of Implantation of Cardioverter-Defibrillators Therapy in Patients with Non-Ischemic Heart Failure: an Updated Systematic Review and Meta-Analysis

Brazilian Journal of Cardiovascular Surgery
Objective: Implantable cardioverter-defibrillator has become the first-line therapy for prevention of sudden cardiac death. Controversial results still exist regarding the effectiveness of implantable cardioverter-defibrillator (ICD) in non-ischemic ...
Zhenhua Xing, Liang Tang, Chenyang Chen, Jiabing Huang, Zhaowei Zhu, Xinqun Hu   +5 more
doaj   +1 more source

Long‐Term Follow‐Up of Patients With Short QT Syndrome: Clinical Profile and Outcome

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Short QT syndrome (SQTS) is a rare inheritable disease associated with sudden cardiac death. Data on long‐term outcomes of families with SQTS are limited.
Ibrahim El‐Battrawy, Johanna Besler, Volker Liebe, Rainer Schimpf, Erol Tülümen, Boris Rudic, Siegfried Lang, Christian Wolpert, Xiaobo Zhou, Ibrahim Akin, Martin Borggrefe   +10 more
doaj   +1 more source

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Myocardial bridge (MB), common anatomic variant, is generally considered benign, while previous studies have shown associations between MB and various cardiovascular pathologies.
Kozo Okada, Kiyoshi Hibi, Yutaka Ogino, Nobuhiko Maejima, Shinnosuke Kikuchi, Hidekuni Kirigaya, Jin Kirigaya, Ryosuke Sato, Hidefumi Nakahashi, Yugo Minamimoto, Yuichiro Kimura, Eiichi Akiyama, Yasushi Matsuzawa, Noriaki Iwahashi, Masami Kosuge, Toshiaki Ebina, Kouichi Tamura, Kazuo Kimura   +17 more
doaj   +1 more source